Positive news for patients of any HCV genotypes! After treatment with AbbVie’s new pangenotypic regimen of glecaprevir/pibrentasvir, results have shown an average SVR rate of 97.5% across all HCV genotypes in only 8 weeks of therapy.
VIDEO: Pangenotypic regimen leads to h... - Hepatitis C Support
VIDEO: Pangenotypic regimen leads to high SVR in all HCV genotypes
Written by
HFIAdmin
To view profiles and participate in discussions please or .
3 Replies
•
That's great but what about sides, during/post treatment?
Not what you're looking for?
You may also like...
I did mavyret for 8 weeks at 4wks I was >15 at 8 wks I was undetected.. so there is a difference I’m guessing?? Anyone had similar results
Just really uncertain if I’m hcv free or not
Help me please!
I just saw my doctor and got the type of hep c and the hcv pcr qt. I'm scared to death...
He said...
Digestive Enzymes: Their role in viral treatment
Effect of Enzymes on Viruses
•The Effects of Plant Form Protease’s on Viruses...
Hep C for over 25 years, maybe a lot longer
I was diagnosed with Hep C when I gave blood at the blood bank some 25 years ago. Who knows how...
Need all the info and help I can get with this disease. New to having Hepatitis C
I just found out I have Hepatitis C. I knew in my gut I had it. I have chronic pain daily and have...